Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively?

International Journal of Colorectal Disease

Volumn 27, Issue 10, 2012, Pages 1347-1357

  Chiang, Sum Fu ^a   Hung, Hsin Yuan ^a   Tang, Reiping ^b   Changchien, Chung Rong ^a   Chen, Jinn Shiun ^a   You, Yau Tong ^a   Chiang, Jy Ming ^a   Lin, Jr Rung ^c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Colorectal; Neutrophil to lymphocyte ratio; Prognostic; Survival

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; COLON CANCER; COLORECTAL CANCER; COLORECTAL SURGERY; CONFIDENCE INTERVAL; DISEASE COURSE; DISEASE FREE SURVIVAL; ELECTIVE SURGERY; FEMALE; HAZARD RATIO; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUTROPHIL COUNT; NEUTROPHIL TO LYMPHOCYTE RATIO; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RECTUM CANCER; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

COLORECTAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEUTROPHILS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; RISK FACTORS; ROC CURVE; SURGICAL PROCEDURES, ELECTIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84867009402     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1459-x     Document Type: Article

References (19)

1. National Cancer Institute. Cancer of the colon and rectum. http:// seer.cancer.gov/statfacts/html/colorect.html. Accessed September 7, 2006
2. Bureau of Health Promotion, Department of Health, R.O.C. (Taiwan). http://www.bhp.doh.gov.tw/BHPnet/Portal/StatisticsShow.aspx?No0200911300001
3. Horner MJ, Ries LAG, Krapcho M et al (2009) SEER cancer statistics review 1975-2006. National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/ 1975-2006
4. Bentzen SM, Balslev I, Pedersen M et al (1992) Time to locoregional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis. Br J Cancer 65(1):102-107
5. Morris EJA, Maughan NJ, Forman D, Quirke P (2007) Who to treat with adjuvant therapy in Dukes' B/stage II colorectal cancer? The need for high quality pathology. Gut 56:1419-1425
6. Petersen VC, Baxter KJ, Love SB, Shepherd NA (2002) Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut 51:65-69
7. Carrato A (2008) Adjuvant treatment of colorectal cancer. Gastrointest Cancer Res 2(4 Suppl):S42-S46
8. Zahorec R (2001) Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102(1):5-14
9. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ (2005) Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91:181-184
10. Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ, Lodge JP (2008) Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 34:55-60
11. Jablonska J, Leschner S, Westphal K, Lienenklaus S, Weiss S (2010) Neutrophils responsive to endogenous IFN-β regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Invest 120(4):1151-1164
12. Hofman PM (2010) Pathobiology of the neutrophil-intestinal epithelial cell interaction: role in carcinogenesis.World J Gastroenterol 16(46):5790-5800
13. Nozawa H, Chiu C, Hanahan D (2006) Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 103(33):12493-12498
14. Nind AP, Nairn RC, Rolland JM, Guli EP, Hughes ES (1973) Lymphocyte anergy in patients with carcinoma. Br J Cancer 28:108-117
15. Calman KC (1975) Tumour immunology and the gut. Gut 16:490-499
16. Waldner M, Schimanski CC, Neurath MF (2006) Colon cancer and the immune system: The role of tumor invading T cells. World J Gastroenterol 12(45):7233-7238
17. Ogino S, Nosho K, Irahara N et al (2009) Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res 15(20):6412-6420
18. McMillan DC, Canna K, McArdle CS (2003) Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 90(2):215-219
19. Stamatiadis AP, Manouras AJ, Triantos GN, Katergiannakis VA, Apostolidis NS (1992) Combination of serum carcino-embryonic antigen and C-reactive protein-a useful test in preoperative staging of colorectal cancer. Eur J Surg Oncol 18(1):41-43